ZVRA · Zevra Therapeutics, Inc. · Documents
$10.33
-0.03 (-0.29%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$614.03M
Shares
59.38M
Volume · Oct 22
537.3K
Avg daily vol (3M)
1.05M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-08-11 | 2026-09-30 | |
| 8-K | — | 2026-08-05 | — | |
| 10-Q | — | 2026-08-05 | 2026-06-30 | |
| 8-K | — | 2026-06-05 | 2026-06-04 | |
| Investor Event Transcript | — | 2026-05-19 | 2026-06-30 | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| 8-K | — | 2026-05-06 | — | |
| DEF 14A | — | 2026-04-20 | 2026-06-04 | |
| PRE 14A | — | 2026-04-06 | — | |
| 8-K | — | 2026-03-16 | 2026-03-12 | |
| 10-K | — | 2026-03-09 | 2025-12-31 | |
| 8-K | — | 2026-03-09 | 2026-03-04 | |
| 8-K | — | 2025-12-17 | 2025-12-11 | |
| 8-K | — | 2025-12-02 | 2025-11-26 | |
| 8-K | — | 2025-11-20 | — | |
| 10-Q | — | 2025-11-05 | 2025-09-30 | |
| 8-K | — | 2025-11-05 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-08-12 | — | |
| 8-K | — | 2025-05-29 | — | |
| DEFA14A | — | 2025-05-21 | — | |
| 10-Q | — | 2025-05-13 | 2025-03-31 | |
| 8-K | — | 2025-05-13 | — | |
| DEFA14A | — | 2025-05-08 | — | |
| DEFA14A | — | 2025-04-21 | — | |
| DEFA14A | — | 2025-04-21 | — | |
| 8-K | — | 2025-04-07 | 2025-04-01 | |
| DEFA14A | — | 2025-04-07 | — | |
| DEFA14A | — | 2025-03-31 | — | |
| DEFA14A | — | 2025-03-31 | — | |
| 10-K | — | 2025-03-12 | 2024-12-31 | |
| 8-K | — | 2025-03-11 | — | |
| 8-K | — | 2025-02-27 | 2025-02-26 | |
| 8-K | — | 2024-12-06 | 2024-12-02 | |
| 8-K | — | 2024-11-22 | 2024-11-21 | |
| 10-Q | — | 2024-11-13 | 2024-09-30 | |
| 8-K | — | 2024-11-12 | — | |
| 8-K | — | 2024-09-20 | — | |
| 10-Q | — | 2024-08-14 | 2024-06-30 | |
| 8-K | — | 2024-08-13 | — | |
| 8-K | — | 2024-08-09 | 2024-08-08 | |
| 8-K | — | 2024-08-08 | — | |
| 8-K | — | 2024-08-05 | 2024-08-02 | |
| 8-K | — | 2024-07-12 | — | |
| 8-K | — | 2024-07-09 | — | |
| S-3 | — | 2024-06-04 | — | |
| 8-K | — | 2024-06-03 | — | |
| 8-K | — | 2024-05-13 | — | |
| 10-Q | — | 2024-05-09 | 2024-03-31 |
Showing 1–50 of 202 filings
Key facts
CIK
1434647
CUSIP
488445206
13F (30d)
22 filings
22 filers
Visit website
Investor relations